---
$id: https://graph.org.ai/products/commodity/51332512
$type: Product
source: UNSPSC
code: "51332512"
title: "Moperone"
class: "51332500"
classTitle: "Antipsychotic butyrophenones"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moperone

**UNSPSC Code**: 51332512
**Class**: [Antipsychotic butyrophenones](Antipsychotic butyrophenones.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anxiolytic with the molecular formula C22H26FNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OU730881W5, chemically known as 4-fluoro-4-(4-hydroxy-4-p-tolylpiperidino)butyrophenone, hydrochloride but generally known as moperone, which bears US NIH Compound Identifier 4249. European Medicines Agency schedules Moperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09057MIG. The term MOPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules moperone in its Anatomical Therapeutic Chemical (ATC) Classification. MOPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moperone under HS 29333999 and SITC 51574. As of Q4 2014, MOPERONE remains the US FDA Preferred Term for this commodity. Moperone bears US NLM identifiers UMLS ID C0066787 and NCI Concept Code C66190. SMILES: FC1CCC(C(=O)CCCN2CCC(O)(CC2)C2CCC(CC2)C)CC1.

